Author

Francesca Orlandi

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Agnese SegalaiD· 1 shared Alessandra ValerioiD· 1 shared Andrea ZendriniiD· 1 shared Angelo MusicòiD· 1 shared Annalisa RadeghieriiD· 1 shared Arabella NevaiD· 1 shared Camillo AlmiciiD· 1 shared Clarissa ConsolandiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Agnese SegalaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Red Blood Cell-derived Extracellular Vesicles enable Cisplatin and Cetuximab combined Therapy against Triple-Negative Breast Cancer

Miriam Romano, Angelo Musicò, Andrea Zendrini, Enrica Gilberti, Francesca Orlandi, Tatiana Pedrazzi, Silvia Alacqua, Agnese Segala, Rossella Zenatelli, Selene Tassoni, Lucia Paolini, Ingrid Cifola, Eleonora Mangano, Clarissa Consolandi, Tania Camboni, , Annalisa Radeghieri

This paper develops a nanoplatform using red blood cell-derived extracellular vesicles to deliver Cetuximab and cisplatin, enhancing cancer cell killing and reducing toxicity in triple-negative breast cancer.

Journal of Nanobiotechnology · Jun 7, 2026Peer-reviewedCell Biology